Marcus A Breden (Marcus Breden)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Electronic Health Record

Top Venues

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Chong Zuo, John M Baer, Brett L Knolhoff, Jad I Belle, Xiuting Liu, Angela Alarcon De La Lastra, Christina Fu, Graham D Hogg, Natalie L Kingston, Marcus A Breden, Paarth B Dodhiawala, Daniel Cui Zhou, Varintra E Lander, C Alston James, Li Ding, Kian-Huat Lim, Ryan C Fields, William G Hawkins, Jason D Weber, Guoyan Zhao, David G DeNardo
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy. The Journal of experimental medicine 220 (6) (2023)
Chong Zuo, John M Baer, Brett L Knolhoff, Jad I Belle, Xiuting Liu, Angela Alarcon De La Lastra, Christina Fu, Graham D Hogg, Natalie L Kingston, Marcus A Breden, Paarth B Dodhiawala, Daniel Cui Zhou, Varintra E Lander, C Alston James, Li Ding, Kian-Huat Lim, Ryan C Fields, William G Hawkins, Jason D Weber, Guoyan Zhao, David G DeNardo
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy. The Journal of experimental medicine 220 (6) (2023)
Andrea Wang-Gillam, Kian-Huat Lim, Robert R McWilliams, Rama Suresh, Albert C Lockhart, Amberly Brown, Marcus A Breden, Jad I Belle, John M Herndon, Savannah J Bogner, Katrina S Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia, Feng Gao, Harry H Yoon, Mojun Zhu, Nikolaos A Trikalinos, Lee Ratner, Olivia Aranha, William G Hawkins, Brett H Herzog, David G DeNardo
Defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment refractory pancreatic cancer: A phase I, dose escalation, and expansion study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)